Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Characterization of B cells in muscle-specific kinase antibody myasthenia gravisJeffrey T Guptill, John S Yi, Donald B Sanders, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.Muscle & Nerve|December 6, 2020
Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravisYingkai Li, C Douglas Emmett, Marjan Cobbaert, et al.Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.Muscle & Nerve|May 26, 2017
Reliability of the triple-timed up-and-go testDonald B Sanders, Jeffrey T Guptill, Kathy L Aleš, et al.Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 2, 2020
AANEM - IFCN glossary of terms in neuromuscular electrodiagnostic medicine and ultrasoundReinhard Dengler, Mamede de Carvalho, Nortina Shahrizaila, et al.Pageof 11